Tag company

Bionovo receives guidance to advance Menerba to Phase 3 Clinical Testing in Europe

Jul28

Pharmaceutical company Bionovo Inc (Nasdaq:BNVI) announced today the receipt of final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company’s lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe.This guidance reportedly defines the clinical and regulatory pathway to a European marketing authorisation for Menerba.The company plans [...]

IASIS Healthcare to Broadcast Its Fiscal Third Quarter 2010 Conference Call Live on the Internet

Jul28

FRANKLIN, Tenn.(BUSINESS WIRE) IASIS Healthcare LLC today announced that it will provide an online Web simulcast of its fiscal third quarter 2010 conference call on Thursday, August 5, 2010. The Company will release its results for the fiscal [...]

Global Health Ventures to Initiate Prototype Manufacturing of a Sublingual Anti-Anxiety Drug

Jul28

VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) 07/29/10 Global Health Ventures Inc. (OTCBB: GHLV) (the "Company"), a specialty pharmaceutical company today announced that it has signed an agreement with Carter Pharmaceutical of Toronto, Canada, to manufacture the prototype of its anti-anxiety drug "Relax-B". Together, the companies will manufacture about 10,000 pills for carrying [...]

Response Genetics, Inc. to Announce Second Quarter 2010 Financial Results

Jul28

LOS ANGELES(BUSINESS WIRE) Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its financial results for this period in a press release to be [...]

American CareSource To Present at the BMO Focus on Healthcare Conference

Jul27

DALLAS(BUSINESS WIRE) American CareSource Holdings (NASDAQ: ANCI) today announced that it will present at the BMO Focus on Healthcare Conference at the Sheraton New York Hotel. David Boone, American CareSource’s Chief Executive Officer and Matthew [...]

Cambridge Heart to Present at 2010 Southern California Investor Conference

Jul27

TEWKSBURY, Mass.(BUSINESS WIRE) Cambridge Heart, Inc. (OTCBB: CAMH), today announced that Ali Haghighi-Mood, President and Chief Executive Officer, is scheduled to present at the upcoming 2010 Southern California Investor Conference sponsored by Global Hunter Securities. [...]

ERF Wireless (OTCBB: ERFW), Smart-Tek Solutions, Inc. (OTCBB: STTN), CytoSorbents Corporation (OTCBB: CTSO), Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS): Sign Up Today!

Jul26

www.OTCtipReporter.com ERF Wireless (OTCBB: ERFW), Smart-Tek Solutions, Inc. (OTCBB: STTN), CytoSorbents Corporation (OTCBB: CTSO), Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS)Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.OTCtipReporter.com/" www.OTCtipReporter.com ERF Wireless Signs Contract With World’s Leading Oil and Gas Services Company in Support of BP and U.S. Coast Guard Gulf [...]

NuVasive Reports Second Quarter 2010 Financial Results

Jul26

SAN DIEGO, CA (MARKET WIRE) 07/27/10 NuVasive, Inc. (NASDAQ: NUVA)
Total revenue of $119.6 million, up 35.2% over second quarter 2009 GAAP earnings of $6.7 million, or $0.17 per share; Non-GAAP earnings of $17.0 million, or $0.42 per share Non-GAAP operating margin of 15.8%, up from [...]

Perrigo Company awarded FDA approval for OTC Cetirizine Cherry Syrup, 1mg/ml

Jul26

Healthcare supplier Perrigo Company (Nasdaq:PRGO) (Nasda:TASE) revealed on Monday the receipt of final approval from the US Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml, for the treatment of indoor and outdoor allergy relief.The company plans to ship Cetirizine Cherry Syrup, 1mg/ml in the fiscal first quarter 2011.According to [...]

Perrigo receives FDA approval for OTC cetirizine cherry syrup

Jul26

Jul 27, 2010 (Datamonitor via COMTEX) Perrigo Company, a developer of OTC and generic prescription pharmaceuticals, has received a final approval from the FDA to manufacture and market over-the-counter, or OTC, cetirizine cherry syrup, 1mg/ml.According to the company, shipments will begin in the company’s fiscal first quarter of 2011. Cherry joins the currently available grape [...]

Your Ad Here